News

TG Therapeutics Announces Data Presentations for BRIUMVI in Multiple Sclerosis at the American Academy of Neurology 2025 Annual Meeting
NEW YORK, April 08, 2025 (GLOBE NEWSWIRE) -- TG Therapeutics, Inc. (NASDAQ: TGTX), today announced the presentation of data highlighting BRIUMVI® (ublituximab-xiiy) in patients with relapsing forms of ...
Fort Worth Weekly7d
AI in the Classroom: Making Student Projects and Presentations Stand Out
Presenting material is no longer the only goal of school projects and presentations; instead, you also need to stand out, ...
News-Medical.Net11d
New data on use of EndoZip™ to treat obese patients be presented at leading global medical conferences
Nitinotes, developer of EndoZip™, a fully automated endoscopic suturing system aimed at treating obesity, today announced that clinical research on the EndoZip™ system will be presented at upcoming ...
Enliven Therapeutics Announces Poster Presentations at the 2025 AACR Annual Meeting
Enliven Therapeutics, Inc. (Enliven or the Company) (Nasdaq: ELVN), a clinical-stage biopharmaceutical company focused on the ...
Boise State University14d
Poster Presentations
In contrast to an oral presentation ... The poster presenter is on hand to answer questions and provide additional details. Keep in mind that the poster needs to attract attention from 10 feet away so ...
Universiteit Utrecht15d
Research on your own teaching: 10 interesting poster presentations
Want to know more about these projects, find them here in the abstract book. It has been an interesting day and we hope all attendees gained knowledge and shared their perspectives on Educational ...
Morningstar17d
Purple Biotech Announces Three Posters Accepted for Presentation at the 2025 American Association for Cancer Research Meeting
today announced upcoming poster presentations including one for CM24 in the treatment of pancreatic cancer, and two for NT219 in the treatment of colorectal and head and neck cancers, at the 2025 ...
manilatimes18d
Gain Therapeutics Announces Poster Presentation at AD/PD 2025
Gain Therapeutics' lead drug candidate, GT-02287, is in clinical development for the treatment of Parkinson's disease (PD) with or without a GBA1 mutation. The orally administered, brain-penetrant ...
The Bakersfield Californian18d
Purple Biotech Announces Three Posters Accepted for Presentation at the 2025 American ...
today announced upcoming poster presentations including one for CM24 in the treatment of pancreatic cancer, and two for NT219 in the treatment of colorectal and head and neck cancers, at the 2025 ...
Nurix Therapeutics Announces Multiple Presentations at the American Association for Cancer Research (AACR) 2025 Annual Meeting
About NRX-0305 NRX-0305 is a potent, selective, and orally bioavailable mutant-specific BRAF degrader that Nurix is exploring for use in oncology. Nurix has reported preclinical data demonstrating ...
Yahoo Finance25d
BioAtla Announces Two Poster Presentations at Upcoming Medical Meetings
today announced two abstracts accepted for poster presentations at the upcoming European Lung Cancer Congress (ELCC) 2025 Scientific Committee and Mayo Clinic Multidisciplinary Head and Neck ...